Suppr超能文献

错失预防 HIV-1 母婴传播的机会:NISDI 围产期和 LILAC 队列研究。

Missed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI Perinatal and LILAC cohorts.

机构信息

Pediatric, Adolescent, and Maternal AIDS Branch, CRMC, NICHD, NIH, DHHS, Bethesda, USA.

出版信息

Int J Gynaecol Obstet. 2012 Oct;119(1):70-5. doi: 10.1016/j.ijgo.2012.05.026. Epub 2012 Jul 21.

Abstract

OBJECTIVE

To evaluate cases of mother-to-child transmission of HIV-1 at multiple sites in Latin America and the Caribbean in terms of missed opportunities for prevention.

METHODS

Pregnant women infected with HIV-1 were eligible for inclusion if they were enrolled in either the NISDI Perinatal or LILAC protocols by October 20, 2009, and had delivered a live infant with known HIV-1 infection status after March 1, 2006.

RESULTS

Of 711 eligible mothers, 10 delivered infants infected with HIV-1. The transmission rate was 1.4% (95% CI, 0.7-2.6). Timing of transmission was in utero or intrapartum (n=5), intrapartum (n=2), intrapartum or early postnatal (n=1), and unknown (n=2). Possible missed opportunities for prevention included poor control of maternal viral load during pregnancy; late initiation of antiretrovirals during pregnancy; lack of cesarean delivery before labor and before rupture of membranes; late diagnosis of HIV-1 infection; lack of intrapartum antiretrovirals; and incomplete avoidance of breastfeeding.

CONCLUSION

Early knowledge of HIV-1 infection status (ideally before or in early pregnancy) would aid timely initiation of antiretroviral treatment and strategies designed to prevent mother-to-child transmission. Use of antiretrovirals must be appropriately monitored in terms of adherence and drug resistance. If feasible, breastfeeding should be completely avoided. Presented in part at the XIX International AIDS Conference (Washington, DC; July 22-27, 2012); abstract WEPE163.

摘要

目的

评估拉丁美洲和加勒比地区多个地点的 HIV-1 母婴传播病例,分析预防失败的原因。

方法

如果 HIV-1 感染的孕妇符合以下条件,则有资格入组:于 2009 年 10 月 20 日之前参加了 NISDI 围产期或 LILAC 方案,且在 2006 年 3 月 1 日之后分娩了已知 HIV-1 感染状态的存活婴儿。

结果

711 名符合条件的母亲中,有 10 名婴儿感染了 HIV-1。传播率为 1.4%(95%CI,0.7-2.6)。传播时间为宫内或分娩期(n=5)、分娩期(n=2)、分娩期或早期产后(n=1)和未知(n=2)。可能存在预防失败的情况包括:妊娠期间母体病毒载量控制不佳;妊娠期间抗逆转录病毒治疗开始较晚;未在临产前行剖宫产术或未在胎膜破裂前行剖宫产术;HIV-1 感染的诊断较晚;未在分娩期使用抗逆转录病毒药物;未完全避免母乳喂养。

结论

早期了解 HIV-1 感染状况(理想情况下在妊娠早期或之前)有助于及时开始抗逆转录病毒治疗,并制定预防母婴传播的策略。必须根据依从性和耐药性适当监测抗逆转录病毒药物的使用。如果可行,应完全避免母乳喂养。本研究部分内容在第 19 届国际艾滋病会议(华盛顿特区;2012 年 7 月 22 日至 27 日)上展示;摘要 WEPE163。

相似文献

1
Missed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI Perinatal and LILAC cohorts.
Int J Gynaecol Obstet. 2012 Oct;119(1):70-5. doi: 10.1016/j.ijgo.2012.05.026. Epub 2012 Jul 21.
2
Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
Obstet Gynecol. 2007 Jun;109(6):1358-67. doi: 10.1097/01.AOG.0000265211.76196.ac.
3
Trends in the management and outcome of HIV-1-infected women and their infants in the NISDI Perinatal and LILAC cohorts, 2002-2009.
Int J Gynaecol Obstet. 2013 Jul;122(1):37-43. doi: 10.1016/j.ijgo.2012.12.021. Epub 2013 Apr 6.
4
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
6
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
7
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
9
Prevention of perinatal HIV transmission during pregnancy.
J Antimicrob Chemother. 2000 Nov;46(5):657-68. doi: 10.1093/jac/46.5.657.
10
Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus.
Obstet Gynecol. 2017 Apr;129(4):621-628. doi: 10.1097/AOG.0000000000001929.

引用本文的文献

1
New diagnosis of mother-to-child transmission of HIV in 8 Latin-American countries during 2018.
BMC Infect Dis. 2022 Apr 7;22(1):347. doi: 10.1186/s12879-022-07311-8.
2
HIV Screening During Pregnancy in a U.S. HIV Epicenter.
Infect Dis Obstet Gynecol. 2020 May 7;2020:8196342. doi: 10.1155/2020/8196342. eCollection 2020.
4
Vertical Transmission of HIV-1 in the Metropolitan Area of Belo Horizonte, Brazil: 2006-2014.
Rev Bras Ginecol Obstet. 2018 Feb;40(2):59-65. doi: 10.1055/s-0037-1613689. Epub 2017 Dec 18.
5
Sustainability of Statewide Rapid HIV Testing in Labor and Delivery.
AIDS Behav. 2018 Feb;22(2):538-544. doi: 10.1007/s10461-017-1920-5.
6
Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus.
Obstet Gynecol. 2017 Apr;129(4):621-628. doi: 10.1097/AOG.0000000000001929.
8
A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes.
Can J Infect Dis Med Microbiol. 2015 May-Jun;26(3):145-50. doi: 10.1155/2015/731043.
9
Experiences of coercion to sterilize and forced sterilization among women living with HIV in Latin America.
J Int AIDS Soc. 2015 Mar 24;18(1):19462. doi: 10.7448/IAS.18.1.19462. eCollection 2015.

本文引用的文献

2
Antiretroviral use during pregnancy for treatment or prophylaxis.
Expert Opin Pharmacother. 2011 Aug;12(12):1875-85. doi: 10.1517/14656566.2011.584062. Epub 2011 May 3.
3
The NICHD International Site Development Initiative perinatal cohorts (2002-09).
Int J Epidemiol. 2012 Jun;41(3):642-9. doi: 10.1093/ije/dyr024. Epub 2011 Feb 27.
6
Targeting points for further intervention: a review of HIV-infected infants born in ireland in the 7 years following introduction of antenatal screening.
J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug;7(4):182-6. doi: 10.1177/1545109708320685. Epub 2008 Jul 14.
9
Risk factors for in utero and intrapartum transmission of HIV.
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):87-95. doi: 10.1097/00126334-200501010-00016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验